Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?

The treatment of peritoneal carcinomatosis (PC) of colorectal origin with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has a 5-year recurrence-free or cure rate of at least 16%, so it is no longer labeled as a fatal disease, and offers prolonged survival for pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortes-Guiral, Delia, Elias, Dominique, Cascales-Campos, Pedro Antonio, Badía Yébenes, Alfredo, Guijo Castellano, Ismael, León Carbonero, Ana Isabel, Martín Valadés, José Ignacio, Garcia-Foncillas, Jesus, Garcia-Olmo, Damian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291843/
https://www.ncbi.nlm.nih.gov/pubmed/28210074
http://dx.doi.org/10.3748/wjg.v23.i3.377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291843/
https://www.ncbi.nlm.nih.gov/pubmed/28210074
http://dx.doi.org/10.3748/wjg.v23.i3.377

Ejemplares similares